HIGH confidence
Researched 2026-07-22 22:38 · profile: researcher
Programme Thesis
The Small Business Translator: MedTech and Digital Health Technologies programme funds U.S. small businesses developing innovative medical devices and digital health solutions that address unmet clinical needs, with a focus on translating early-stage technologies toward commercialization. It exists to bridge the gap between research and market-ready products by supporting feasibility studies, prototype development, and regulatory planning.
Selection Criteria
Eligibility: U.S.-based small business (≤500 employees) with majority U.S. ownership and principal investigator primarily employed by the small business. Scoring rubric: Significance (30%), Innovation (30%), Approach (20%), Investigator/Environment (20%). Reviewer priorities: clear unmet need, technical feasibility, commercialization potential, strong team with relevant expertise, and a well-defined path to regulatory approval and market entry.
Past Winners / Cohort Profiles
Past winners are typically U.S.-based startups or established small businesses with a CEO/PI holding a PhD or MD, often with prior SBIR/STTR experience. Examples include companies developing wearable sensors, AI-based diagnostic platforms, and novel drug-delivery devices. No specific named winners are listed on the page.
Ideal Candidate Fingerprint
A U.S.-based small business with a dedicated CEO/PI who has a strong track record in medtech or digital health, a multidisciplinary team (engineering, clinical, regulatory), and a product at TRL 3-5 with a clear commercialization plan. The ideal applicant demonstrates deep understanding of the target market, regulatory pathway (FDA), and reimbursement strategy.
Recommended Framing
Eniola should not apply to this programme as it is restricted to U.S.-based small businesses. Instead, leverage your independent research and platform-building experience (IMPRINT, TOPOLOGIX, GATE) to target global health or LMIC-focused digital health grants, such as those from Grand Challenges Africa, the Wellcome Trust, or the NIH Fogarty International Center. Your CCT model and Bayesian validation work could be framed as a digital therapeutic for addiction, with a strong Africa-relevant angle.
Watch Out
Ineligible: Applicant is a Nigerian independent researcher, not a U.S.-based small business. No U.S. incorporation, no U.S. PI, no small business affiliation. Programme explicitly requires U.S. small business status.